Paradigm Biocapital Advisors LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$350.2B
Holdings
24
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 260,115 | $38.2B | 10.90% | |
| 2 | ASNDASCENDIS PHARMA A/S | 218,158 | $29.3B | 8.38% | |
| 3 | ZNTLZENTALIS PHARMACEUTICALS INC | 300,434 | $25.3B | 7.21% | |
| 4 | VRDNVIRIDIAN THERAPEUTICS INC | 1,209,051 | $23.9B | 6.83% | |
| 5 | ARNAEURARENA PHARMACEUTICALS INC | 251,777 | $23.4B | 6.68% | |
| 6 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 780,480 | $22.8B | 6.52% | |
| 7 | ARVNARVINAS INC | 268,519 | $22.1B | 6.30% | |
| 8 | LEGNLEGEND BIOTECH CORP | 385,967 | $18.0B | 5.14% | |
| 9 | IOVAIOVANCE BIOTHERAPEUTICS INC | 844,005 | $16.1B | 4.60% | |
| 10 | SGENUSDSEAGEN INC | 100,687 | $15.6B | 4.45% | |
| 11 | ARGXARGENX SE | 42,050 | $14.7B | 4.21% | |
| 12 | OPHTEURIVERIC BIO INC | 815,581 | $13.6B | 3.89% | |
| 13 | IM8NINSMED INC | 394,358 | $10.7B | 3.07% | |
| 14 | —SIERRA ONCOLOGY INC | 474,945 | $10.3B | 2.95% | |
| 15 | SNDXSYNDAX PHARMACEUTICALS INC | 453,091 | $9.9B | 2.83% | |
| 16 | GLPGGALAPAGOS NV | 167,824 | $9.3B | 2.64% | |
| 17 | CCCCC4 THERAPEUTICS INC | 258,746 | $8.3B | 2.38% | |
| 18 | KYMRKYMERA THERAPEUTICS INC | 125,858 | $8.0B | 2.28% | |
| 19 | VORVOR BIOPHARMA INC | 629,342 | $7.3B | 2.09% | |
| 20 | ENTAENANTA PHARMACEUTICALS INC | 75,507 | $5.6B | 1.61% | |
| 21 | OYSTOYSTER PT PHARMA INC | 304,238 | $5.6B | 1.59% | |
| 22 | IMCRIMMUNOCORE HLDGS PLC | 134,249 | $4.6B | 1.31% | |
| 23 | ESPRESPERION THERAPEUTICS INC NE | 839,257 | $4.2B | 1.20% | |
| 24 | GRCLGRACELL BIOTECHNOLOGIES INC | 545,388 | $3.3B | 0.94% |